PMID int64 27.8M 36.2M | Title/Abstract stringlengths 7 10.7k | MeshTerms stringlengths 7 104 | SemanticTypes stringlengths 4 84 |
|---|---|---|---|
34,670,425 | hemodynam effect ketamin compar propofol dexmedetomidin continu icu sedat ketamin seen increas use sedat intens care unit contrast propofol dexmedetomidin ketamin may provid posit effect hemodynam | D020927;D007022;D007649;D015742 | T033;T121;T109 |
34,670,424 | estim preval type diabet combin diabet kidney diseas identif associ factor patient attend primari hospit anhui provinc china evalu preval type diabet mellitus tdm chronic kidney diseas dm ckd identifi associ factor patient attend primari hospit anhui provinc china | D003924;D003928 | T047 |
34,670,423 | analysi outpati expenditur trend use korean health panel survey data patient diagnos lumbar intervertebr disc herniat studi aim analyz cost trend outpati treatment lumbar intervertebr disc herniat ldh | D007403;D010045 | T023;T101 |
34,670,422 | decis tree analysi evalu diseas activ patient rheumatoid arthriti rheumatoid arthriti ra chronic inflammatori autoimmun diseas character inflammatori synov develop new diseas activ evalu system use import cytokin help doctor better evalu diseas activ patient ra | D001172;D013585 | T047 |
34,670,421 | comparison arterioven fistula construct main intern branch cephal vein retrospect analysi case evalu effect matur arterioven fistula avf use intern branch cephal vein compar main branch cephal vein | D001164;D001166 | T190;T061 |
34,670,419 | coronavirus diseas stroke multisystem natur coronavirus diseas becom increas clear cours pandem neurolog vascular system affect impact acut stroke impact conceptualis direct indirect effect diseas direct effect coronavirus diseas stroke thought relat receptor mediat tissu invas mark inflammatori respons presenc virus effect includ coagulopathi endotheli system inflamm atherosclerot plaqu instabl possibl long term cardiovascular effect indirect effect impact aspect stroke care deliveri extend far beyond direct effect coronavirus diseas repres essenti focus stroke system care articl detail impact coronavirus diseas acut stroke | D000086382;D058226;D020521 | T047;T046;T067;T020;T031 |
34,670,418 | relationship hyperglycemia waist circumfer cours covid mortal risk assess observ studi conduct ukrain determin independ mortal risk among adult inpati covid result treatment covid inpati n present waist circumfer wc measur logist regress analysi appli evalu effect factor risk mortal odd ratio cis associ calcul one hundr three subject fast plasma glucos level met diabet mellitus criteria mmoll patient diabet mellitus previous known two hundr eleven patient diabet hyperglycemia diabet mellitushyperglycemia odd ratio ci p lose statist signific standard age waist circumfer fast plasma glucos effect gender bodi mass index determin obes hypertens found fast plasma glucos mmoll age year waist circumfer cm categori associ or ci ci ci respect optim model mortal risk auc ci includ diabetesheperglycemia age categori well waist circumfer continu variabl waist circumfer independ risk factor mortal inpati covid | D006943;D055105 | T033;T047;T201 |
34,670,416 | west lake stage new stage system orchestr x ray mri knee osteoarthr purpos investig differ x ray mri among stage knee osteoarthr koa propos new stage system call west lake wl stage method cross section studi conduct patient koa stage ii iii iv divid base stepwis treatment strategi knee osteoarthr koa joint space width jsw measur x ray wherea cartilag injuri ci bone marrow lesion bml evalu mri differ across group calcul test receiv oper characterist roc curv render obtain area curv auc youden index correspond cut point result eventu signific differ jsw ci bml stage iiiii iiiiv signific differ stage iii stage iiiii auc jsw ci bml youden index meanwhil cut point mm stage iiiiv auc jsw ci bml youden index meanwhil cut point mm conclus wl stage describ follow stage x ray show joint space narrow normal mri mri show cartilag degener section involv bml stage ii x ray show joint space narrow mri show cartilag defect full thick cartilag defect meanwhil section involv bml stage iii x ray show serious joint space narrow even jsw disappear mri show full thick cartilag defect section involv bml | D002358;D020370 | T047;T024 |
34,670,415 | model integr approach breast cancer patient breast cancer bc survivor physic psycholog need requir convinc respons health care provid qualiti life issu clinic unmet need among main reason push number patient toward natur therapi often mislead altern mainstream cancer care integr oncolog io tri respond mani need combin lifestyl counsel bodi mind activ complementari evid inform therapi anticanc standard treatment | D001943;D000529;D000073196 | T091;T191;T061 |
34,670,414 | intoler uncertainti distress women delay ivf treatment due covid pandem mediat role situat apprais cope strategi covid pandem caus delay numer medic procedur includ ivf studi investig relationship intoler uncertainti iu situat apprais perceiv threat covid pose infertil treatment cope strategi general distress among women delay ivf procedur sem show situat apprais partial mediat relationship iu avoid well relationship iu general distress connect situat apprais general distress partial mediat avoid challeng context mental health situat apprais cope strategi determin level distress iu disposit variabl repres main determin entir reaction | D000086382 | T047;T067 |
34,670,412 | comput tomographi perfus base predict core infarct tissu risk artifici intellig help reduc radiat exposur explor feasibl autom arteri input function independ vendor neutral predict core infarct penumbr tissu use complet partial comput tomograph perfus data set neural network | D016571;D011829 | T170;T081 |
34,670,408 | endotheli gnaq prq increas angpt angiopoietin drive format enlarg blood vessel capillari malform cm occur sporad associ sturg weber syndrom somat mosaic mutat gnaq cg prq enrich endotheli cell ec skin cm sturg weber syndrom brain cm goal investig mutant gq g protein q subunit alter ec signal disrupt capillari morphogenesi approach result use lentivir construct express prq wild type gnaq normal human endotheli coloni form cell ec rq ec wt respect ec rq constitut activ plc phospholipas c downstream effector gq activ plc also detect human cm tissu section bulk rna sequenc analys mutant versus wild type ec indic constitut activ pkc protein kinas c nf b nuclear factor kappa b calcineurin signal ec rq increas express downstream target pathway angpt angiopoietin dscr syndrom critic region protein confirm quantit pcr immunostain human cm tissu section gq inhibitor ym well sirna target plc reduc mrna express level target ec rq pan pkc inhibitor aeb reduc angpt dscr ec rq form enlarg blood vessel mice reminisc found human cm shrna knockdown angpt ec rq normal enlarg vessel size compar form ec wt | D009389 | T046 |
34,670,406 | pd l program death ligand regul cell differenti control adapt venous remodel patient end stage renal diseas depend hemodialysi surviv although arterioven fistula avf prefer vascular access hemodialysi primari success rate avf within month show urgent need improv pd l program death ligand ligand regul cell activ sinc cell import role avf matur hypothes pd l regul cell control venous remodel occur avf matur approach result mous aortocav fistula model anti pd l antibodi mg wk intraperiton given inhibit pd l activ avf matur inhibit pd l increas helper type cell helper type cell reduc regulatori cell increas type macrophag reduc type macrophag chang associ reduc vascular wall thicken reduc avf patenc inhibit pd l also inhibit smooth muscl cell prolifer increas endotheli dysfunct effect anti pd l antibodi adapt venous remodel diminish nude mice howev restor cell transfer nude mice indic effect anti pd l antibodi venous remodel depend cell | D002454 | T043 |
34,670,405 | socioeconom geograph characterist hospit establish transcathet aortic valv replac program despit benefit novel therapeut inequit diffus new technolog may generat dispar examin growth transcathet aortic valv replac tavr unit state understand characterist hospit develop tavr program socioeconom status patient hospit serv | D001024;D065467 | T047;T061 |
34,670,404 | prevent abdomin adhes polycaprolactonephospholipid hybrid film contain quercetin silver nanoparticl aim develop quercetin load poli caprolacton pcl soybean phosphatidylcholin pc film coat silver ag prevent format postop adhes poa materi method film prepar use solvent cast method coat ag underw vitro test vivo studi conduct employ anim model sidewal defect cecum abras result film show sustain releas behavior quercetin ag coat film ag improv antimicrobi activ vivo studi confirm superior antiadhes properti film compar control group evalu gross observ histochem stain immunohistochemistri analys conclus ag q pcl pc film potenti candid prevent poa act sustain releas deliveri system physic barrier | D053768;D012834 | T196;T073 |
34,670,403 | bodi composit inflamm impact non small cell lung cancer patient treat first line immunotherapi background immunotherapi chang landscap non small cell lung cancer nsclc effort made implement action studi aim describ bodi composit nutrit inflammatori status nsclc patient treat first line immunotherapi correl variat impact patient method retrospect analyz consecut patient receiv pembrolizumab treatment result therapi inflamm viscer fat increas wherea muscl subcutan fat decreas paramet relat inflamm interest prognost impact high number white blood cell remain signific correl high risk death multivari model conclus best treatment choic combin clinic biolog factor like necessari prospect larger studi multidimension approach need | D001823 | T032 |
34,670,402 | per polyfluoroalkyl substanc epigenet age dna methyl cross section studi firefight background per polyfluoroalkyl substanc pfass persist chemic firefight encount epigenet modif includ dna methyl could serv pfass toxic biomark method sampl size firefight quantifi serum concentr nine pfass blood leukocyt dna methyl epigenet age indic via epic array examin associ pfass epigenet age site region specif dna methyl adjust confound result perfluorohexan sulfon perfluorooctano pfoa sum branch isom perfluorooctan sulfon sm pfos associ acceler epigenet age branch pfoa linear pfos perfluorononano perfluorodecano perfluoroundecano associ differenti methyl loci region conclus pfass concentr associ acceler epigenet age locus specif dna methyl implic pfass toxic merit investig | D019175;D044127;D061388 | T090;T044;T045 |
34,670,400 | polygen risk score coronari arteri diseas improv predict earli onset myocardi infarct mortal men sever risk factor coronari arteri diseas cad describ genet determin use polygen risk score prs could improv cad risk assess predict accuraci accord age sex well establish | D003324;D009203 | T047 |
34,670,399 | target tumor microenviron ewe sarcoma ewe sarcoma aggress tumor type age peak adolesc despit use dose intensifi chemotherapi well radiat surgeri local control patient upfront metastat diseas relaps diseas dismal prognosi highlight need addit therapeut option differ type immunotherapi investig limit clinic success may due presenc immunosuppress factor tumor microenviron provid overview differ factor contribut ewe sarcoma immun escap demonstr way target factor order make current futur immunotherapi effect achiev deeper durabl respons patient ewe sarcoma | D007167 | T061 |
34,670,397 | character tissu scaffold use synchrotron radiat microcomput tomographi imag distinguish tradit imag synchrotron radiat microcomput tomographi sr ct imag allow visual three dimension object interest nondestruct andor situ way better spatial resolut deep penetr relat fast speed andor high contrast sr ct illustr promis visual character tissu scaffold repair replac damag tissu organ tissu engin te particular advanc longitudin monitor track success scaffold implant anim model andor human patient articl present comprehens review recent studi character scaffold base sr ct take scaffold architectur properti mechan properti degrad swell wettabl biolog properti five separ section introduc sr ct wide applic also discuss highlight uniqu opportun sr ct various te applic conclud articl suggest futur research direct includ prospect applic sr ct along challeng method improv field te | D017356;D054457 | T122;T073 |
34,670,396 | genotyp guid py inhibitor therapi percutan coronari intervent bayesian analysi among patient receiv percutan coronari intervent pci role genotyp guid approach antiplatelet therapi compar usual care unclear conduct bayesian analysi entir tailor pci tailor antiplatelet initi lessen outcom due decreas clopidogrel respons percutan coronari intervent random clinic trial popul evalu effect genotyp guid antiplatelet therapi post pci compar usual care risk major advers cardiovascular event mace | D062645 | T061 |
34,670,395 | better die diseas die hunger experi igw tradit ruler fight covid pandem rural south east nigeria covid pandem serious health socioeconom impact peopl world expect africa would hardest hit consequ nigeria african nation work non govern organis institut framework control spread diseas result econom woe measur howev larg focus urban centr wherea spread virus diseas transcend import urban case spread rural communiti studi explor experi tradit ruler closest rural peopl fight covid | D000086382;D007722;D058873;D012424 | T047;T098;T053;T067;T102 |
34,670,392 | bibliometr analysi research relat radiat induc lung injuri radiotherapi one common mean cancer treatment especi treatment lung cancer howev radiat therapi caus lung tissu radiat lung injuri studi diseas reduc incid avoid occurr radiat pulmonari fibrosi past year studi radiat induc lung injuri rili attract attent paper extract main text inform rili relat literatur woscc databas use citespac vosview visual analysi present result found past year articl rili number articl publish reach peak unit state main leader research field among univ texa md anderson cancer center publish mani research result field activ author liao zhongx influenti journal int j radiat oncol provid platform scholar relat field publish articl current research focus main random control trial relat rili relationship dose volum histogram analysi rili format protect normal lung tissu effect stereoscop radiotherapi rili pathogenesi rili studi format mechan rili main research direct includ apoptosi mechan epitheli endotheli cell cytokin cascad theori immun mechan regul process oxid stress mechan etc | D055370;D011832 | T047;T037 |
34,670,391 | phase ii studi chidamid combin cisplatin patient metastat tripl negat breast cancer platinum base regimen mainstay treatment advanc tripl negat breast cancer tnbc preclin studi shown histon deacetylas hdac inhibitor chidamid induc antitumor effect tnbc chidamid plus chemotherapi shown toler sever malign studi sought investig efficaci safeti combin treatment chidamid cisplatin metastat tnbc patient | D064726 | T191 |
34,670,390 | platelet rich plasma combin ozon prevent cartilag destruct improv weight bear asymmetri surgeri induc osteoarthr rabbit model osteoarthr oa common degen diseas older adult treatment remain unsatisfactori studi aim evalu effect explor therapeut mechan combin platelet rich plasma prp ozon knee oa | D002358;D020370;D010126;D053657 | T031;T047;T024;T103 |
34,670,389 | day surpris question use screen tool predict prognosi patient advanc cancer multicent prospect observ studi cancer patient near death predict prognosi physician crucial studi examin use day surpris question dsq | D009369;D010166 | T191;T061 |
34,670,388 | low mortal covid nurs facil franc follow combin prevent activ treatment protocol aim studi retrospect describ evolut symptom infect mortal nurs facil franc implement protocol prevent treatment covid | D000086382 | T047;T067 |
34,670,387 | potenti inappropri medic discontinu chang base pharmacist recommend older end stage cancer patient receiv palliat care cross section studi avoid potenti inappropri medic pim reduc advers event older cancer patient receiv palliat care howev studi examin extent pharmacist recommend reduc prescript pim therefor design cross section studi determin extent recommend play role reduc prescript pim older cancer patient receiv palliat care | D009369;D000067561 | T080;T191 |
34,670,386 | lung metastasi lymph node metastasi risk factor hyperprogress diseas primari liver cancer patient treat immun checkpoint inhibitor present cancer patient experi hyperprogress diseas hpd receiv immunotherapi studi use respons evalu criteria solid tumor evalu incid hpd patient receiv immun checkpoint inhibitor ici treat primari liver cancer plc explor risk factor hpd | D002289;D008113;D008175 | T191 |
34,670,385 | preoper nutrit state associ mid long term mortal cardiac surgeri frailti score develop determin physiolog function capac aim research explor relationship frailti factor mortal cardiac surgeri patient | D006348;D000073496 | T033;T046;T184;T061 |
34,670,384 | predictor clinic outcom rotat atherectomi facilit percutan coronari intervent hemodialysi patient percutan coronari intervent pci hemodialysi patient sever calcifi diffus lesion associ extrem high rate major advers cardiovascular event mace even facilit rotat atherectomi rota potenti risk factor mace rota facilit pci hemodialysi patient identifi | D017225;D003324;D062645 | T047;T061 |
34,670,383 | predict util postop serum myoglobin acut kidney injuri liver transplant acut kidney injuri aki common multifactori complic liver transplant lt myoglobin mb serv storag deliveri depot present muscl cardiac myocyt previous studi shown close relationship mb aki lack clinic studi mb risk aki due lt studi perform determin associ serum level mb incid aki patient underw lt | D058186;D016031 | T061;T047;T037 |
34,670,382 | hypofraction radiat therapi palliat manag symptomat local control advanc thorac malign radiat therapi play import role symptom palliat intrathorac malign inelig curat intent therapi limit data exist regard role stereotact bodi radiat therapi sbrt versus conform radiat intrathorac tumor palliat report efficaci hypofraction rt palliat sbrt symptom manag durabl control lung non lung intrathorac tumor | D008175;D016634 | T191;T061 |
34,670,381 | cost effect analysi glecaprevirpibrentasvir regimen treat chines patient chronic hepat c genotyp genotyp infect hepat c virus hcv infect import health threat china direct act antivir daa effect anoth novel daa glecaprevirpibrentasvir glepib offici approv knowledg cost effect would inform clinic decis make evalu studi aim evalu cost effect glepib inform polici make drug reimburs hcv erad | D000998;D019698 | T047;T121 |
34,670,378 | neurolymphomatosi multifoc peripher nerv involv case report infiltr invas nerv trunk nerv root cranial nerv lymphomat malign cell defin neurolymphomatosi main caus lymphoma cell direct infiltr peripher nerv low incid neurolymphomatosi rare condit neoplast endoneuri invas primari secondari non hodgkin lymphoma leukemia describ case primari peripher neurolymphomatosi multifoc involv year old male patient present left lower limb pain diagnos cd diffus larg b cell lymphoma dlbcl magnet reson imag mri fluorin fluorodeoxyglucos f fdg positron emiss tomographi pet comput tomographi ct nerv biopsi contribut diagnosi genom profil program death ligand pd l express tumor mutat burden tmb also assess cdknacdknb delet identifi pd l express assess antibodi posit tmb sampl mutsmb patient respond well rituximab combin chemotherapi howev die cycl chemotherapi due sever lung infect subsequ complic respiratori failur report clinic radiolog patholog molecular find patient affect multifoc neurolymphomatosi without system involv organ | D060890;D000077162 | T129;T191;T116 |
34,670,377 | novel ceruloplasmin gene mutat caus aceruloplasminemia diabet chines woman case report hereditari aceruloplasminemia acp rare adult onset autosom recess diseas character ceruloplasmin cp gene mutat defect absent cp function present studi report case acp year old chines woman diabet fatigu anxieti progress membran loss low hemoglobin associ microcytosi fast glucos level mmoll postprandi blood glucos rang mmoll stumvol first phase second phase insulin secret disposit indic low serum iron content low even though transferrin level normal moreov transferrin satur low ferritin level extrem high gl patient furthermor serum cp level extrem low cp gene diagnos acp date less famili case acp report worldwid two case acp report china report case acp accompani diabet novel mutat cp gene suggest increas awar highlight disord diabet import typic symptom | D002570;D003920 | T116;T047;T126 |
34,670,376 | best system treatment newli diagnos inflammatori breast cancer narrat review propos review discuss system treatment option newli diagnos inflammatori breast cancer ibc includ recent data immun checkpoint inhibitor cdk inhibitor anti therapi aim provid pragmat treatment gray area concern issu real world practic | D058922 | T191 |
34,670,375 | manag complic brain metastasi treatment narrat review describ rang potenti side effect associ modern brain metastasi treatment provid evidenc base guidanc effect manag side effect | D001932;D016634 | T191;T061 |
34,670,374 | birth solid organ cancer cell fusion hypothesi present pancreat cancer model narrat review hypothesi driven narrat review aim explor evid fundament process cell fusion normal differ cell type genesi cancer cell | D000970;D010190 | T191;T121;T109 |
34,670,368 | respons carbon polym dot optic super resolut fluoresc lifetim imag nucleic acid live cell rapid develop advanc optic imag method includ stimul emiss deplet sted fluoresc lifetim imag microscopi flim provid power tool real time observ submicromet biotarget achiev unpreced spatial tempor resolut howev practic imag qualiti often limit perform fluoresc probe lead unsatisfactori result particular long term imag nucleic acid live cell sted flim remain desir yet challeng due lack compet probe combin target specif biocompat low power requir photost work ration design synthes nanos carbon polym dot cpd materi cpds high effici photost emiss super resolut fluoresc lifetim imag nucleic acid live cell fabric nanoprob show respons emiss properti upon bind nucleic acid provid excel signal nois ratio spatial tempor dimens moreov characterist satur intens valu cpds low mw mwcm allow direct observ chromatin structur subdiffract resolut nm low excit w deplet power mw owe low toxic high photon effici outstand photost cpds capabl perform long term imag sted flim setup demonstr great potenti dynam studi nucleic acid function long run | D061848 | T060 |
34,670,362 | discoveri dual tubulin poli adp ribos polymeras inhibitor structur base pharmacophor model virtual screen molecular dock biolog evalu dual inhibit tubulin poli adp ribos polymeras parp may becom attract approach cancer therapi discov dual tubulinparp inhibitor term tp use structur base virtual screen tp show strong dual inhibitori effect tubulin parp cellular assay reveal tp show superior antiprolif activ human cancer cell includ breast liver ovarian cervic cancer studi indic tp play antitumor role multipl mechan includ disturb microtubul network parp dna repair function accumul dna doubl strand break inhibit tube format induct gm cell cycl arrest apoptosi vivo assess indic tp inhibit growth mda mb xenograft tumor nude mous notabl side effect data demonstr tp dual target high efficaci low toxic antitumor agent | D055808 | T062 |
34,670,334 | micronucleus test nuclear abnorm assay zebrafish danio rerio past present futur trend nuclear abnorm na assay fish wide appli toxic risk assess field laboratori condit zebrafish danio rerio becom suitabl model system assess na induc pollut thus current studi aim summar discuss literatur concern micronucleus mn na zebrafish applic toxic screen environment risk assess data concern public year pollut type experiment design type na induc pollut summar also molecular mechan caus na zebrafish discuss revis data show mn test zebrafish appli sinc mn frequent na nuclear alter report zebrafish notch nuclei bleb nuclei binucl cell bud lobe nuclei bridg kidney shape sever pollut induc na zebrafish main effluent mixtur pollut agrochem microplast pollut induc na zebrafish depend experiment design ie exposur time concentr exposur condit development stage celltissu type type pollut besid research gap recommend futur studi indic overal current studi show zebrafish suitabl model assess pollut induc mutagen | D010969;D015027 | T167;T013 |
34,670,330 | amberlyst catalys synthesi novel indol deriv ultrasound irradi evalu serotonin ht c receptor agonist seri indol base novel schiff base design potenti agonist ht c receptor support dock studi silico compound synthes via amberlyst catalys condens appropri pyrazol base primari amin correspond indol aldehyd ultrasound irradi ambient temperatur number target schiff base obtain good yield mild condit within h notabl methodolog afford correspond pyrazolo pyrimidin h one deriv primari amin replac secondari amin sever schiff base show agonist activ test human ht c use luciferas assay hekt cell vitro sar structur activ relationship studi suggest imin moieti favor cyclic form ie correspond pyrazolopyrimidinon ring schiff base b ec nm ec nm identifi activ compound compar lorcaserin ec nm also like lorcaserin none compound found pam ht c fold select toward ht c ht ht b respect compound reduc locomotor activ zebrafish danio rerio larva model emerg promis hit molecul studi | D000069453 | T070;T061 |
34,670,328 | report mja lancet countdown health climat chang australia increas limb mja lancet countdown health climat chang australia establish produc first nation assess first annual updat second annual updat examin indic across five broad domain climat chang impact exposur vulner adapt plan resili health mitig action health co benefit econom financ public polit engag special report focus unpreced catastroph australian bushfir season highlight indic explor relationship health climat chang bushfir return report full suit indic across five domain ad new indic find australian increas expos vulner excess heat alreadi limit way life increas risk heat stress outdoor sport decreas work product across rang sector weather extrem also rise result escal social econom health impact climat chang disproportion threaten indigen australian wellb multipl complex way respons threat find posit action individu local state territori level grow uptak rooftop solar electr vehicl begin appropri adapt plan howev sever undermin nation polici action contrari increas place australia limb australia respond well covid public health crisi still emerg bushfir crisi preced need respond prepar health crise result climat chang | D057231;D003247;D004190;D011634 | T064;T078;T091;T067;T081;T070;T069 |
34,670,326 | repeat ethanol exposur follow avoid condit impair avoid extinct modifi condit associ prefront dendrit chang mous model post traumat stress disord treatment post traumat stress disord complic presenc alcohol use disord comorbid littl known under brain mechan recent shown mice post traumat stress disord like phenotyp characteris increas decreas total dendrit number length prelimb infralimb area medial prefront cortex respect examin whether repeat ethanol exposur would exacerb chang whether would associ difficulti extinguish passiv avoid behaviour indic treatment resist also analys whether known trauma associ chang like increas decreas corticosteron decreas brain deriv neurotroph factor level would also exacerb male mice underw trauma exposur footshock follow day later condit place prefer train ethanol test fear sensit passiv avoid anxieti like behaviour extinct acquisit relaps suscept use assess behaviour chang plasma corticosteron brain deriv neurotroph factor level prefront dendrit chang subsequ measur trauma suscept mice expos ethanol acquir strong place prefer behav differ expos ethanol delay avoid extinct higher avoid relaps vulner ethanol potenti trauma associ dendrit chang prelimb area suppress trauma associ dendrit chang infralimb area howev ethanol effect trauma induc increas corticosteron decreas brain deriv neurotroph factor level data suggest modif prefront trauma relat chang due alcohol use characteris probabl support treatment resist post traumat stress disord | D013313 | T048 |
34,670,325 | video consult parent child newli diagnos type diabet qualit studi except coronavirus pandem video consult part standard care children diabet germani virtual diabet outpati clinic children adolesc vidiki studi investig effect month supplementari video consult standard care one year qualit substudi investig experi famili child newli diagnos type diabet mellitus tdm receiv least four week supplementari video consult | D003922;D017216 | T058;T047 |
34,670,323 | antenat corticosteroid decreas risk composit neonat respiratori morbid plan earli term cesarean deliveri administr antenat corticosteroid prior term elect cesarean deliveri shown intern random control trial decreas rate respiratori distress syndrom transient tachypnea newborn standard practic unit state aim determin administr antenat corticosteroid fetal lung matur within week schedul earli term cesarean deliveri result decreas composit respiratori morbid | D047928;D012127;D059245 | T047;T046 |
34,670,322 | intent receiv covid vaccin pregnanc systemat review meta analysi meta analysi aim assess level intent receiv coronavirus diseas covid vaccin demograph factor influenc vaccin uptak among pregnant individu | D000086382;D007252;D007251 | T047;T121;T109;T129;T067 |
34,670,317 | rehabilit patient interstiti cystitisbladd pain syndrom icbp unsuccess outpati conserv treatment invas inpati treatment cystectomi interstiti cystitisbladd pain syndrom icbp inpati disciplin specif urolog rehabilit rehab propos accord german guidelin icbp rehab diagnost result complet multimod therapi includ optimis lifestyl medic intens psychotherapi may frequent improv process diseas various form exercis therapi physic therapi water applic thermotherapi sever form massag electr magnet therapi well nutrit advic frequent allevi complaint icbp differ therapi modifi rehab necessari social medicin evalu advic eg grade handicap abil work also import issu rehab two third patient show essenti improv rehab last prolong period patient | D018856 | T047 |
34,670,316 | hereditari kidney cancer easili clarifi diagnos toscana recent year great improv diagnosi differenti hereditari syndrom predisposit kidney cancer achiev assum kidney cancer hereditari origin realiti number probabl much higher mani genet aspect kidney cancer still entir known hereditari kidney cancer usual show two characterist properti median age diagnosi sporad renal cell carcinoma year patient hereditari tumor predisposit year younger time diagnosi addit tumor often occur multifocalbilater therefor special manag extend diagnost necessari young kidney cancer patient literatur mani report hereditari syndrom kidney cancer predisposit exist though paper usual put focus singl syndrom rather aspect kidney cancer goal articl present practic urologist compact overview import hereditari syndrom kidney cancer predisposit improv primari diagnost treatment renal cancer patient relat | D002292;D007680;D009386 | T191 |
34,670,314 | acut liver failur dog mushroom intak presum genus amanita year old neuter male huski mix dog weigh kg report ingest mushroom like genus amanita one day prior present exhibit sign diarrhea vomitus inappet progress worsen lethargi clinic chemistri reveal hypoglycemia hyperbilirubinemia decreas prothrombin thromboplastin time well increas liver enzym activ despit hospit support therapi period day dog general condit worsen lead euthanasia pathomorpholog find character hemorrhag sever organ hemorrhag ingesta icterus mark hepat cellular necrosi | D004283;D017114;D009145 | T047;T037 |
34,670,313 | tick born enceph dog tick born enceph tbe infecti diseas transmit tick rare diagnos dog diagnosi tbe virus infect live anim base simultan presenc typic clinic neurolog sign acut rapid progress cours diseas detect tbe specif antibodi cerebrospin fluid virus detect blood cerebrospin fluid well presenc pleocytosi cerebrospin fluid case describ result perform test led assumpt presenc tbe addit hyperthermia central nervous disord ataxia hyperaesthesia seizur chang behavior classic symptom clinic overt tbe frequent includ neck pain flexion cervic spine case describ chronic form diseas regener period sever month document treatment base symptomat measur specif therapi date contrast human medicin vaccin tbe current approv use veterinari field therefor tick prophylaxi possibl prevent tbe dog | D004283;D004669;D004675 | T047;T005 |
34,670,312 | chronic enteropathi cat diagnost therapeut approach chronic enteropathi character persist recurr gastrointestin sign includ vomit diarrhoea weight loss anorexia lethargi minimum durat week diagnosi exclud diseas process includ faecal examin blood screen e g thyroid pancreat liver dysfunct investig infecti diseas vitamin b status diagnost imag histopatholog evalu use biopsi sever differ gastrointestin segment respons therapeut trial chronic inflammatori enteropathi classifi food respons enteropathi fre antibiot respons enteropathi immunosuppress respons similar refractori enteropathi ire small cell low grade alimentari lymphoma lgal crucial differenti diagnosi predomin seen older cat felin chronic enteropathi activ index fceai clinic score system establish object assess sever clinic ill evalu respons treatment general prognosi depend under aetiolog cat diagnos fre typic good long term prognosi adequ dietari manag respons treatment vari cat ire cat experienc frequent relaps clinic sign still other non respons treatment prognosi lgal adequ treatment usual fair good median surviv time day | D002371;D015212;D008223 | T191;T047 |
34,670,311 | examin common swift apus apus salmonella shed area hannov lower saxoni germani avail literatur indic high preval zoonot pathogen salmonella enterica serovar infanti common swift apus apus long distanc migrant consum aerial plankton reach high popul densiti place suitabl breed site dedic compet privat person take part hand rear juvenil common swift wildlif rescu centr unavoid result close contact avian patient reason examin common swift shed salmonella spp | D001717;D012475 | T007;T012 |
34,670,310 | clinic relev intraderm test result atop dog canin atop dermat ad inflammatori prurit skin diseas case associ ige antibodi environment allergen date causat therapeut option allergen immunotherapi ait offend allergen ait identifi intraderm test idt serum allergen specif ige test aim studi evalu posit idt result consid atop dog clinic histori | D003876;D004283 | T047 |
34,670,309 | vaccin yes reason influenc vaccin decis dog owner survey respons privat dog owner breeder veterinarian dog import companion mani peopl live high prioriti lead differenti consider regard health care anim also regard vaccin studi reason vaccin decis privat dog owner breeder well possibl influenc factor analyz compar inform provid particip veterinarian | D004283;D018634 | T097;T047 |
34,670,308 | common veterinari practic small anim anesthesia onlin survey among small anim practition europ survey concern situat small anim anesthesia europ assess complianc guidelin ava american societi anesthesiologist dvg specialti group vain veterinari anesthesia intens care emerg medicin pain manag | D000758;D000777 | T039;T121;T061 |
34,670,306 | complet androgen insensit syndrom rare case prenat diagnosi widespread uptak noninvas prenat test nipt larger cohort women access fetal chromosom sex increas potenti identifi prenat sex discord prenat diagnosi androgen insensit syndrom ai incident rare find wish present diagnosi prenat index case nipt cell free fetal dna mismatch fetal sex ultrasound phenotyp particular case molecular analysi androgen receptor ar gene show presenc pathogen mutat previous report consist complet androgen insensit syndrom carrier test mother reveal presenc variant confirm matern hemizyg inherit identif molecular basi genet condit enabl preimplant prenat diagnosi futur pregnanc | D013734 | T047 |
34,670,305 | supplement vitamin postdeliveri period women previous gestat diabet mellitus systemat review meta analysi random trial evalu effect vitamin supplement postpartum period women previous gestat diabet mellitus gdm | D016640 | T047 |
34,670,304 | expos implant immedi breast reconstruct present analysi clinic manag protocol infect exposur implant common concern complic implant base breast reconstruct current consensus manag complic aim present studi review case present clinic protocol | D018427;D001943;D016462 | T191;T074;T061 |
34,670,303 | pathway ifn alpha activ patient cervic intraepitheli neoplasia cin aim present studi compar local system express factor link interferon alpha ifn activ pathway differ degre cervic intraepitheli neoplasia cin cervic cancer | D018290;D002583 | T191 |
34,670,302 | psycholog problem experienc patient bowel endometriosi await surgeri assess common psycholog disturb women deep endometriosi bowel involv wait surgic treatment evalu form cope use solv problem | D004715 | T191;T047 |
34,670,301 | associ advers matern clinic outcom imbal cytokin angiogen factor preterm preeclampsia preeclampsia pe pregnanc specif syndrom character abnorm level cytokin angiogen factor play role diseas develop present studi evalu whether immunolog marker associ gestat age diseas sever preeclampt women | D011225;D040281 | T192;T116;T046;T126 |
34,670,300 | tempor evolut matern mortal determin profil matern death occur period hospit de clnica de porto alegr hcpa portugues acronym compar matern death institut | D063130;D011248 | T040;T046 |
34,670,299 | clinic experi year b lynch compress sutur techniqu manag postpartum hemorrhag describ clinic experi b lynch techniqu manag postpartum hemorrhag well factor relat indic techniqu present success rate applic b lynch techniqu | D006473 | T046 |
34,670,298 | understand health provid identifi women postpartum hemorrhag qualit studi identifi health provid recogn postpartum hemorrhag earli difficulti involv | D006176;D009774;D006473 | T091;T046 |
34,670,296 | use immuno oncolog therapi hepatocellular carcinoma context liver transplant interdisciplinari benefitrisk assess multipl system therapi option recent approv treatment hepatocellular carcinoma hcc particular immuno oncolog combin therapi achiev impress respons rate signific prolong surviv good toler immuno oncolog io base combin current evalu therapi advanc hcc increas also earlier stage term peri intervent therapi concept also size local therapi context liver transplant ltx particular critic benefitrisk assess must made use immunotherapeut context multimod concept sinc risk potenti lethal reject signific increas immunotherapi | D006528;D008113;D016031 | T191;T061 |
34,670,295 | frequenc synchron malign liver lesion initi detect ultrasound patient newli diagnos under non hematolog malign diseas retrospect studi patient studi describ frequenc malign synchron focal liver lesion flls patient newli diagnos non hematolog malign diseas | D001650;D018281;D008113;D018358 | T191 |
34,670,294 | accept sar cov vaccin liver transplant recipi candid guidelin recommend vaccin sar cov transplant recipi candid household contact howev littl known accept covid vaccin groupsin march survey liver transplant recipi candid household contact determin accept rate factor influenc accept covid vaccin patient household contact return questionnair nineti percent patient return survey report will receiv vaccin within next month alreadi start vaccin patient household contact report refus vaccin patient household contact want postpon vaccin concern side effect receiv influenza vaccin last season strongest indic accept receiv sar cov vaccin within month odd ratio confid interv p thirti two percent respond patient report fear side effect reason refus vaccin beforealthough accept sar cov vaccin particular high among german liver transplant recipi candid household contact survey transplant physician encourag discuss safeti concern patient refus season influenza vaccin past | D000086382;D016031 | T047;T061;T067 |
34,670,293 | implement applic program interfac promi measur three medic center increas bodi literatur advoc collect patient report outcom pros clinic care unfortun mani barrier integr pro measur particular comput adapt test cat within electron health record ehr therebi limit access advanc pro measur clinic care set | D057286;D000071066 | T170;T073 |
34,670,292 | visit questionnair tool augment communic decreas provid document burden pediatr diabet develop evalu electron tool collect interv histori incorpor provid summari note | D003920;D004282 | T047;T170 |
34,670,288 | racial ethnic dispar cancer associ thrombosi activ malign increas risk develop venous thromboembol vte four seven fold risk vte includ deep vein thrombosi pulmonari embol patient cancer vari base sever clinic factor cancer stage age howev race ethnic also associ increas vte risk black african american patient cancer higher risk develop vte white patient asianpacif island lower risk studi cancer associ thrombosi demonstr need advanc understand biolog sociolog underpin observ differ accord race address caus dispar better health outcom histor underserv patient popul | D009369;D013927;D054556 | T047;T191;T046 |
34,670,278 | deep afppr identifi novel antifung peptid use pretrain embed seqvec dcnn bilstm fungal infect mycosi caus wide rang diseas human anim incid communiti acquir nosocomi fungal infect increas dramat emerg covid pandem increas number patient immunodefici immunosuppress relat diseas resist exist antifung compound avail limit therapeut option trigger search altern antifung molecul direct antifung peptid afp receiv lot interest altern current avail antifung drug although afp produc divers popul live organ identifi effect afp natur sourc time consum expens therefor need develop robust silico model capabl identifi novel afp protein sequenc paper propos deep afppr deep learn classifi identifi afp protein sequenc develop deep afppr use concept transfer learn dcnn bilstm deep learn algorithm find reveal deep afppr beat state art afp classifi wide margin achiev approxim precis valid test data respect base propos approach onlin predict server creat made public avail https afppredanvilapp use server one identifi novel afp protein sequenc result provid report includ predict peptid physicochem properti motif util model identifi afp differ protein chemic synthes lab experiment valid antifung activ | D000086382;D009091;D000086402 | T047;T005;T067 |
34,670,277 | aminolevulin acid induc porphyrin content various brain tumor implic regard imag devic design valid fluoresc guid resect use aminolevulin acid ala induc tumor porphyrin establish adjunct malign glioma surgeri base phase iii studi use specif adapt microscop visual fluoresc protoporphyrin ix ppix new hardwar technolog introduc claim perform origin technolog visual fluoresc assum qualit fluoresc detect equival establish standard assumpt need critic assess | D001932;D005910;D011166 | T191;T109;T123 |
34,670,276 | high dose rate interstiti spine brachytherapi use intraop mobil comput tomographi guid surgic navig system previous irradi metastat spine tumor progress irradi tumor pose signific risk exceed radiat toler spinal cord high dose rate hdr brachytherapi treatment altern | D001918;D000085022 | T074;T061 |
34,670,275 | high risk relaps diseas patient nkt cell chronic activ epstein barr virus diseas outsid asia chronic activ epstein barr virus ebv diseas caebv character high level ebv predomin andor natur killer cell lymphoprolifer organ failur due infiltr tissu virus infect cell hemophagocyt lymphohistiocytosi andor lymphoma diseas common asia unit state europ although allogen hematopoiet stem cell transplant hsct consid curat therapi caebv efficaci best treatment modal reduc diseas sever prior hsct unknown retrospect assess intern cohort patient outsid asia treatment diseas vari wide although patient ultim proceed hsct though patient undergo hsct better surviv vs p still high rate death group mortal larg affect age ethnic cell type involv diseas complic develop lymphoma show trend increas mortal vs p overwhelm major patient die hsct succumb relaps diseas caebv remain challeng treat advanc diseas present outcom would like improv better diseas control strategi earlier referr hsct close follow hsct includ aggress manag rise ebv dna level blood | D020031;D008232;D055611 | T025;T191;T047 |
34,670,274 | suprabulbar approach jugular fossa tumor dimension oper video owe scarciti locat intric neurovascular associ jugular fossa tumor among challeng patholog encount neurosurgeon paraganglioma origin within often occlud jugular bulb schwannoma meningioma extra bulbar typic imped venous flow schwannoma typic aris extradur origin expand jugular foramen meningioma intradur caus hyperostosi jugular tubercl describ expos resect jugular fossa tumor presigmoid suprabulbar infralabyrinthin window detail cadaver studi approach maintain patenc jugular bulb without breach labyrinth manipul facial nerv applic case partial impair hear intact lower cranial nerv carotid arteri identifi neuronavig micro doppler ultrasonographi approach provid direct later trajectori short distanc jugular fossa cerebellopontin angl earli exposur central debulk tumor minim manipul exquisit sensit lower cranial nerv distal aspect tumor remov endoscop assist techniqu first patient yr old woman previous irradi schwannoma present worsen neurolog deficit extradur suprabulbar approach use resect tumor second patient yr old woman enlarg meningioma associ neurolog dysfunct tumor resect use suprabulbar approach open presigmoid dura patient consent surgeri public imag imag reprint arnautovi et al permiss jnspg imag ossama al mefti reus permiss | D008577;D008579;D009442 | T191 |
34,670,269 | effect orthodont forc dental pulp histomorpholog tissu factor express evalu effect orthodont forc histomorpholog tissu factor express dental pulp | D003782;D013925 | T129;T023;T116 |
34,670,265 | new primari immunodefici context futur primari immunodefici diseas pid also call inborn error immun iei genet disord classic character increas suscept infect andor disrupt regul immunolog pathway review summar highlight new iei disord iui report interim report discuss direct futur manag pid | D000086382;D007153;D000081207 | T047;T067 |
34,670,264 | covid mrna vaccin allergi known histori sever allerg reaction eg anaphylaxi compon vaccin contraind coronavirus diseas covid mrna vaccin import pediatrician understand likelihood allerg reaction covid mrna vaccin includ excipi | D000707;D000086382 | T047;T067;T046 |
34,670,263 | acut central peripher nervous system injuri associ coronavirus diseas recognit treatment strategi acut central peripher nervous system injuri may occur associ coronavirus diseas covid caus infect sever acut respiratori syndrom coronavirus virus review assist reader recogn neurolog manifest associ covid includ common life threaten symptom diagnost test also review current recommend treatment neurolog injuri associ covid infect children | D000086382;D009422;D020521 | T047;T067 |
34,670,262 | cutan coronavirus diseas children clinic primer diagnosi treatment review examin global literatur regard rash encount children adult infect sever acut respiratori syndrom coronavirus sar cov aim provid practic pediatrician understand relationship instanc rash coronavirus diseas covid children order effect evalu treat patient | D000086382;D012871 | T047;T067 |
34,670,261 | progress understand climat chang effect children youth climat chang remain major threat health well children global articl review myriad health effect climat chang children throughout live discuss way general pediatrician advoc climat solut | D000397;D057231 | T080;T070;T069 |
34,670,259 | comprehens assess implement factor relat worksit exercis firefight studi sought identifi key implement factor month worksit exercis intervent career firefight | D061388;D017216 | T058;T090 |
34,670,258 | mortal men women work us base petrochem refineri oper updat describ mortal trend men women work various petrochem refineri oper us base compani | D001195;D000086002;D009369;D009784;D010578 | T191;T047;T109 |
34,670,257 | versatil subscapular system flap head neck oncolog reconstruct review analyz differ way appli subscapular system flap sssf conveni versatil solut larg varieti head neck oncolog defect | D058752;D006258;D019651 | T191;T024;T061 |
34,670,256 | make better decis dyston voic manag optim diagnosi manag dyston voic disord root nuanc understand phenomenolog distinguish subtyp vocal dystonia challeng audibl physic present dystonia seem similar also lack scientif consensus regard diagnost criteria condit help improv clinician acumen focus outlin classif top three neurolog voic disord notabl spasmod dysphonia spasmod dysphonia tremor essenti tremor voic also provid algorithm approach base current evid base literatur guid practition clinic diagnosi manag possibl etiolog | D055154;D014831 | T040;T048;T047;T184 |
34,670,255 | gram negat endocard diseas present diagnosi treatment gram negat bacilli gnb caus infect endocard ie episod caus microorgan haemophilus spp aggregatibact spp cardiobacterium spp eikenella spp kingella spp hacek group frequenc ie caus non hacek gnb ie increas recent year uncertainti persist regard best medic treatment appropri time surgic treatment addit new drug activ multiresist microorgan littl experi diseas review topic answer frequent ask question aris among colleagu | D044066;D004696;D004697 | T007;T047 |
34,670,254 | imag find immunotherapi relat renal toxic immunotherapi relat advers event ira associ immun checkpoint inhibitor affect near organ system includ common lumin gastrointestin tract hepatobiliari system lung endocrin gland skin mani describ imag manifest patient without clinic suspect ira imag find may first indic abnorm prompt workup facilit earli detect initi appropri treatment therapi discontinu corticosteroid therapi ira well describ imag correl pneumon hypophys coliti other well describ nephriti report case ira nephriti associ pd inhibitor therapi imag featur | D064420;D009369;D009393 | T047;T191;T046;T037 |
34,670,253 | experi home care nurs covid pandem covid pandem provok sever chang home care understand home care nurs experi covid pandem play essenti role home care manag | D000086382;D006699;D009726 | T058;T047;T097;T067 |
34,670,252 | vertic comit hypertropia congenit acquir superior obliqu palsi ivanir trobe claim hypertropia ht greater upgaz downgaz equal characterist decompens congenit superior obliqu palsi never present ischem traumat tumor palsi reliabl claim test patient palsi confirm mri demonstr subnorm ipsilesion size | D013285;D020432 | T047 |
34,670,249 | alter oral microbiom hiv infect caus effect potenti intervent massiv deplet cd lymphocyt describ earli acut human immunodefici virus hiv infect lead imbal human microbiom immun respons recent year grow interest alter gut microbiota hiv infect led mani studi howev studi conduct explor import oral microbiom hiv infect individu evid indic dysbiosi oral microbiota peopl live hiv plwh potenti mechan might relat immunodefici oral caviti hiv infect individu includ chang secretori compon reduc level enzym protein saliva alter cellular compon involv reduct dysfunct innat adapt immun cell result disrupt oral immun hiv infect individu lead imbal oral microbiom local immun respons may contribut develop hiv relat diseas hiv associ non acquir immunodefici syndrom comorbid although introduct antiretrovir therapi art led signific decreas occurr opportunist oral infect hiv infect individu dysbiosi oral microbiom persist furthermor sever studi aim investig abil probiot regul dysbiosi oral microbiota hiv infect individu ongo howev effect art probiot oral microbiom hiv infect individu remain unclear articl review composit oral microbiom healthi hiv infect individu possibl effect oral microbiom hiv associ oral diseas also discuss art probiot influenc oral microbiom hiv infect believ deeper understand composit function oral microbiom critic develop effect prevent therapeut strategi hiv infect | D000069196;D015658;D064307 | T007;T047;T001;T032;T028 |
34,670,248 | risk factor associ osteoporosi fractur psoriat arthriti although studi mention may relationship psoriat arthriti psa osteoporosi clinic data real world still need clarifi china aim studi assess areal volumetr bone miner densiti bmd frequenc fractur risk factor patient psa | D015535;D010024;D058866 | T047 |
34,670,246 | circular rnas peripher blood mononuclear cell ankylos spondyl circular rna circrna type close circular noncod rna ncrna most form back splice altern splice pre messeng rna mrna aim studi explor express profil circrna peripher blood mononuclear cell pbmcs patient ankylos spondyl discov potenti molecular marker | D000079962;D013167 | T047;T114 |
34,670,244 | cardiovascular risk profil clinic characterist diabet patient cross section studi china cardiovascular cv diseas lead caus morbid mortal adult type diabet td aim studi determin cv risk chines patient td base european societi cardiolog esc european associ studi diabet easd guidelin diabet pre diabet cv diseas | D002318;D003924 | T047 |
34,670,242 | vulvar high grade squamous intraepitheli lesion cancer risk factor anal cancer review anal squamous cell carcinoma ascc higher incid describ certain group name women vulvar high grade squamous intraepitheli lesion vhsil andor human papillomavirus squamous cell carcinoma vscc review describ terminolog vhsil vscc associ ascc publish recommend earli detect cancer women | D001005;D002278;D000081483;D014846 | T033;T191 |
34,670,241 | establish deaf american sign languag inclus resid program improv divers resid program increas emphas mean address gender racial ethnic dispar medicin howev limit attent given potenti benefit train physician differ gender race ethnic american disabl repres us popul wherea physician traine report disabl nation survey identifi physician traine report deaf hear loss disabl date publish strategi creat inclus program deaf traine herein author report develop deaf american sign languag asl inclus resid program serv academ model program medic specialti seek creat access train program deaf physician adapt traine disabl march radiat oncolog resid program john hopkin univers match asl sign deaf resid would begin program juli prepar depart leadership engag key stakehold leader within univers health system among depart faculti resid staff well incom resid creat asl inclus program step transit process train program ultim develop implement author focus engag deaf traine interpret engag health system department leadership contract train consult develop oral written train materi faculti staff optim workspac via accommod collabor prepar deaf asl sign resid success integr resid program propos step transit process provid effect engag model encourag institut seek employ similar inclus initi | D007396;D010820 | T097;T065 |
34,670,240 | increas pediatr resid class divers improv patient outcom address structur racism racial ethnic makeup physician unit state reflect communiti serv address dispar may improv patient outcom combat structur racism | D007396;D063505 | T097;T065;T054 |
34,670,239 | develop telemedicin curriculum compet graduat medic educ outcom modifi delphi process telemed applic recent begun coalesc field telemedicin due vari definit telemedicin issu around reimburs process acceler covid pandem ensu expans telemedicin deliveri articl demonstr develop set propos compet telemedicin curriculum graduat medic educ | D000086382;D017216 | T058;T047;T067 |
34,670,238 | novel onlin curriculum coach strategi expand addict medicin workforc michigan collabor addict resourc educ system shortag addict medicin physician year period build workforc via practic pathway enabl physician combin experienti hour pass board exam becom board certifi physician afterward specialist need complet tradit fellowship pathway requir addit train | D003479;D000071252 | T065;T170 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.